uMI Panvivo vs OPTIS Mobile Next Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

uMI Panvivo

by Shanghai United Imaging Healthcare Co., Ltd.

OPTIS Mobile Next Imaging

by Abbott Medical

AI Verdict

Tool A, uMI Panvivo, is an AI-powered PET/CT system for broad diagnostic imaging across oncology, cardiology, and neurology. In contrast, Tool B, OPTIS Mobile Next Imaging, is an AI-powered intravascular imaging system (OCT/Physiology) specifically designed to guide percutaneous coronary intervention (PCI) procedures in cath labs. While both utilize AI in cardiology imaging, their distinct modalities and applications make them adjacent rather than direct competitors, serving different stages of patient care.

Choose uMI Panvivo if…

Choose uMI Panvivo if your institution requires a comprehensive, high-resolution AI-powered PET/CT system for advanced diagnostic precision across oncology, cardiology, and neurology. Its exceptional spatial and TOF timing resolution, combined with intelligent workflows, makes it ideal for detailed anatomical and metabolic imaging crucial for complex disease diagnosis and treatment planning.

View uMI Panvivo →

Choose OPTIS Mobile Next Imaging if…

Choose OPTIS Mobile Next Imaging if your cath lab needs a transportable, AI-powered intravascular imaging system for real-time guidance during PCI procedures. This system excels at providing high-resolution OCT and coronary physiology measurements (RFR/FFR) on a single platform, enabling immediate, informed decision-making and enhanced workflow efficiency at the bedside.

View OPTIS Mobile Next Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	uMI Panvivo	OPTIS Mobile Next Imaging
Pricing	Contact for pricing	Unknown
Deployment	On-premise (scalable modality, departmental, or enterprise solution; compact design allows installation in smaller spaces without a dedicated equipment room).	On-premise (mobile cart system integrated into catheterization laboratories)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OPTIS Mobile Next Imaging

Tool B, OPTIS Mobile Next Imaging, offers a Wireless Tableside Controller (TSC) for full control at the bedside and rapid image processing with less than three-second pullback speed, directly enhancing the clinician's immediate operational efficiency during procedures. While Tool A, uMI Panvivo, features AI-powered workflows and patient comfort elements, Tool B's features provide more direct and agile control at the point of care.

Clinical Value

Tie

Both tools offer significant clinical value within their specific domains. Tool A, uMI Panvivo, provides high-resolution diagnostic PET/CT imaging across oncology, cardiology, and neurology. Tool B, OPTIS Mobile Next Imaging, delivers highly specialized, real-time guidance for interventional cardiology procedures (PCI) through AI-powered OCT and coronary physiology measurements. Their distinct applications make a direct comparison of overall clinical value difficult, as both are highly impactful in their respective fields.

Pricing & Value

uMI Panvivo

Tool A, uMI Panvivo, provides a clearer long-term value proposition by explicitly stating that 'Lifetime software and functionality upgrades included with active service agreement' and offering 'All-in configurations with every available application included upfront.' This offers greater cost predictability and ensures the system remains current. Tool B, OPTIS Mobile Next Imaging, does not provide any pricing details or information on upgrade policies in the provided facts.

Enterprise Readiness

uMI Panvivo

Tool A, uMI Panvivo, explicitly describes itself as a 'scalable modality, departmental, or enterprise solution' and confirms it 'has a BAA' (Business Associate Agreement), which is critical for data privacy and large-scale deployments. While Tool B, OPTIS Mobile Next Imaging, emphasizes seamless integration with cath lab IT systems and DICOM, its BAA status is less explicitly stated for the device itself, and its enterprise scalability is not as broadly articulated.

Innovation

Tie

Both tools demonstrate significant innovation. Tool A, uMI Panvivo, innovates with its high NEMA spatial resolution and exceptional TOF timing resolution in an AI-powered PET/CT system, alongside advanced AI workflows for multi-specialty diagnostics. Tool B, OPTIS Mobile Next Imaging, integrates AI-powered OCT, coronary physiology measurements, and simultaneous angio co-registration into a mobile system with a wireless controller for real-time interventional guidance, representing a unique and advanced solution for its specific application.

Support & Docs

uMI Panvivo

Tool A, uMI Panvivo, explicitly states that 'Lifetime software and functionality upgrades included with active service agreement,' which is a strong indicator of ongoing product support and commitment to keeping the system up-to-date. Tool B, OPTIS Mobile Next Imaging, does not provide any information regarding support, documentation, or upgrade policies in the provided facts.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	uMI Panvivo	OPTIS Mobile Next Imaging
Name	uMI Panvivo	OPTIS Mobile Next Imaging
Company	Shanghai United Imaging Healthcare Co., Ltd.	Abbott Medical
Primary Use	AI-powered PET/CT system for advanced diagnostic precision in oncology, cardiology, and neurology.	AI-powered, transportable intravascular imaging system for cath labs, offering high-resolution OCT and coronary physiology measurements to guide PCI procedures.
Key Imaging/Measurement Technologies	PET/CT (High NEMA spatial resolution (2.9mm), Exceptional TOF timing resolution (219 ps))	Optical Coherence Tomography (OCT) intravascular imaging, Coronary physiology measurements (RFR/FFR)
Target Specialties	Nuclear Medicine, Oncology, Radiology	Cardiology

Videos

Demos, reviews, and walkthroughs featuring uMI Panvivo and OPTIS Mobile Next Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools cater to the specific diagnostic and interventional needs within their respective clinical specialties?

uMI Panvivo offers advanced diagnostic precision with high-resolution PET/CT imaging and intelligent workflows for oncology, cardiology, and neurology, supporting comprehensive diagnostic needs. OPTIS Mobile Next Imaging is an AI-powered intravascular imaging system specifically designed for cath labs, providing high-resolution OCT and coronary physiology measurements to guide PCI procedures and inform interventional decisions.

How do the AI-powered features of each system specifically enhance workflow efficiency during diagnostic imaging versus interventional procedures?

uMI Panvivo utilizes AI-powered workflows such as uVision, EasyRange, OncoFocus, and NeuroFocus to streamline diagnostic PET/CT imaging and analysis. OPTIS Mobile Next Imaging leverages AI technology (Ultreon Software) for faster information display, rapid image processing with less than three-second pullback, and a wireless tableside controller to optimize workflow during PCI procedures.

What are the key performance metrics related to image resolution and diagnostic or measurement accuracy that differentiate these systems for their intended clinical applications?

uMI Panvivo boasts high NEMA spatial resolution (2.9mm) and exceptional TOF timing resolution (219 ps) for precise PET/CT diagnostics. OPTIS Mobile Next Imaging provides high-resolution Optical Coherence Tomography (OCT) intravascular imaging and accurate coronary physiology measurements (RFR/FFR) on a single platform to guide interventional decisions.

Beyond standard DICOM, what is the depth of integration with existing hospital IT systems for each tool, particularly for data flow and reporting?

OPTIS Mobile Next Imaging offers seamless and secure integration with cath lab IT systems and DICOM, facilitating efficient data flow within the interventional environment. While uMI Panvivo is a scalable PET/CT system, its specific depth of integration beyond standard imaging protocols with broader hospital IT systems is not detailed in the provided information.

For healthcare systems with multiple facilities or multiple labs, what are the key considerations for deploying these systems?

uMI Panvivo is a scalable platform with a compact, air-cooled design that allows installation in smaller spaces, making it suitable for multi-site enterprise solutions. OPTIS Mobile Next Imaging is a transportable system designed for use in multiple cath labs within a facility via easy pre-installed connections, optimizing its utility across different interventional suites.

What is the expected learning curve for a physician and their team to become proficient with each system, and how quickly can clinical value be realized?

uMI Panvivo's intelligent workflows aim to simplify operation, and its lifetime software upgrades suggest ongoing value, though proficiency with a PET/CT system requires training. OPTIS Mobile Next Imaging's AI-powered efficiency, rapid image processing, and wireless controller are designed to reduce the learning curve and provide fast image acquisition and interpretation, contributing to quicker clinical decision-making.